FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Promotes Centralized Statistical Trial Monitoring

[ Price : $8.95]

FDA encourages drug sponsors to use centralized statistical monitoring to help keep an eye on clinical trial integrity issues.

McKinsey & Co. Pays $650 Million in Opioid Case

[ Price : $8.95]

McKinsey & Co. agrees to pay $650 million to settle both criminal and civil investigations into its advisory work with Purdue Phar...

DTC Ad Enforcement to Increase Under Trump: Panel

[ Price : $8.95]

Lawyers on a Food & Drug Law Institute enforcement panel warn that the incoming Trump administration is likely to target and seek ...

FDA Sees New Ocaliva Liver Injuries

[ Price : $8.95]

FDA says it has identified serious liver injuries in patients without cirrhosis of the liver being treated for primary biliary cho...

Keros Halts Some Dosing in Cibotercept Trial

[ Price : $8.95]

Keros Therapeutics stops some dosing in a Phase 2 clinical trial of cibotercept (KER-012) in combination with background therapy i...

FDA Hasnt Inspected Factory with Recalls: ProPublica

[ Price : $8.95]

A detailed ProPublica investigative report says FDA failed to inspect a Glenmark Pharmaceuticals facility in India that had multip...

Trump Unclear on Abortion Pills in Interview

[ Price : $8.95]

In a Time interview, president-elect Donald Trump said it has always been his commitment to preserve access to abortion pills, but...

Generics Seek Legislation to End Drug Sameness Delays

[ Price : $8.95]

The Association for Accessible Medicines urges Congress to pass pending legislation to allow FDA to disclose sameness information ...

FDA Launches RWE Evidence Innovation Center

[ Price : $8.95]

FDA launches the CDER Center for Real-World Evidence Innovation with four areas of initial focus.

U.S. Approves More New Drugs than EU, Japan: Analysis

[ Price : $8.95]

An IQVIA analysis of novel active substance approvals from 2014 to 2022 in the U.S., EU, and Japan shows the U.S. approves more ne...